AR006216A1 - PHARMACEUTICAL COMPOSITIONS INCLUDING PEPTIDES FOR SUSTAINED RELEASE, METHOD FOR THE PREPARATION, USE OF A GELABLE PEPTIDE SALT TO PREPARE MEDICINES AND CONTAINING MEDICINES - Google Patents
PHARMACEUTICAL COMPOSITIONS INCLUDING PEPTIDES FOR SUSTAINED RELEASE, METHOD FOR THE PREPARATION, USE OF A GELABLE PEPTIDE SALT TO PREPARE MEDICINES AND CONTAINING MEDICINESInfo
- Publication number
- AR006216A1 AR006216A1 ARP970101003A ARP970101003A AR006216A1 AR 006216 A1 AR006216 A1 AR 006216A1 AR P970101003 A ARP970101003 A AR P970101003A AR P970101003 A ARP970101003 A AR P970101003A AR 006216 A1 AR006216 A1 AR 006216A1
- Authority
- AR
- Argentina
- Prior art keywords
- medicines
- sustained release
- peptide salt
- preparation
- pharmaceutical compositions
- Prior art date
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 5
- 239000003814 drug Substances 0.000 title abstract 4
- 150000003839 salts Chemical class 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 238000013268 sustained release Methods 0.000 title abstract 2
- 239000012730 sustained-release form Substances 0.000 title abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 229940079593 drug Drugs 0.000 abstract 2
- 210000001124 body fluid Anatomy 0.000 abstract 1
- 239000010839 body fluid Substances 0.000 abstract 1
- 230000003993 interaction Effects 0.000 abstract 1
- 230000002045 lasting effect Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 238000007911 parenteral administration Methods 0.000 abstract 1
- 239000007787 solid Substances 0.000 abstract 1
- 239000008247 solid mixture Substances 0.000 abstract 1
Landscapes
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Una composición farmacéutica, no particulada, de liberación sostenida para la administración parenteral a un paciente, composición que consisteesencialmente en (1) una sal de péptido gelificable, y (2) hasta 30 por ciento por peso de unvehícu lo soluble, monomérico, farmacéuticamente aceptable,compuesta en una forma de sólido cilíndrico, en la cual la composición sólida automática forma un gel tras la interacción con los fluidos corporales delpaciente, y libera el péptido demanera cont inua dentro del paciente en el curso de un período de por lo menos tres días de duración, método para supreparación, uso de una sal de péptido gelificable para preparar medicamentos y medicamentos que los contienen.A sustained release, nonparticulate pharmaceutical composition for parenteral administration to a patient, a composition consisting essentially of (1) a gellable peptide salt, and (2) up to 30 weight percent of a soluble, monomeric, pharmaceutically acceptable vehicle , composed in a cylindrical solid form, in which the automatic solid composition forms a gel upon interaction with the patient's body fluids, and continuously releases the peptide within the patient over the course of a period of at least three days lasting, method for overcoming, use of a gellable peptide salt to prepare drugs and medicines containing them.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ARP970101003A AR006216A1 (en) | 1997-03-13 | 1997-03-13 | PHARMACEUTICAL COMPOSITIONS INCLUDING PEPTIDES FOR SUSTAINED RELEASE, METHOD FOR THE PREPARATION, USE OF A GELABLE PEPTIDE SALT TO PREPARE MEDICINES AND CONTAINING MEDICINES |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ARP970101003A AR006216A1 (en) | 1997-03-13 | 1997-03-13 | PHARMACEUTICAL COMPOSITIONS INCLUDING PEPTIDES FOR SUSTAINED RELEASE, METHOD FOR THE PREPARATION, USE OF A GELABLE PEPTIDE SALT TO PREPARE MEDICINES AND CONTAINING MEDICINES |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR006216A1 true AR006216A1 (en) | 1999-08-11 |
Family
ID=51929462
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP970101003A AR006216A1 (en) | 1997-03-13 | 1997-03-13 | PHARMACEUTICAL COMPOSITIONS INCLUDING PEPTIDES FOR SUSTAINED RELEASE, METHOD FOR THE PREPARATION, USE OF A GELABLE PEPTIDE SALT TO PREPARE MEDICINES AND CONTAINING MEDICINES |
Country Status (1)
| Country | Link |
|---|---|
| AR (1) | AR006216A1 (en) |
-
1997
- 1997-03-13 AR ARP970101003A patent/AR006216A1/en not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2169762T3 (en) | CONTINUOUS RELEASE OF PEPTIDES FROM PHARMACEUTICAL COMPOSITIONS. | |
| ES2151079T3 (en) | PREPARATION OF SUSTAINED RELEASE CONTAINING A METALLIC SALT OF A PEPTIDE. | |
| ES2178430T3 (en) | USE OF GELIFICABLE PHARMACEUTICAL COMPOSITIONS IN PARODONTOLOGY. | |
| ATE19589T1 (en) | PHARMACEUTICAL THREE-LAYER FILM PREPARATIONS WITH LONG-LASTING EFFECTS. | |
| CO4340618A1 (en) | PHARMACEUTICAL COMPOSITION FOR CONTROLLED RELEASE | |
| BR9808888A (en) | Dosage forms and method of improving male erectile dysfunction | |
| CO4750822A1 (en) | TADA PHARMACEUTICAL FORMULATIONS FOR THE ADMINISTRATION IN THE GASTROINTESTINAL TRACT AND PROCESSES TO PREPARE THE SAME | |
| CO5261582A1 (en) | VALDECOXIB COMPOSITIONS | |
| BRPI0015567B8 (en) | compound, pharmaceutical composition, dosage unit form, use of the pharmaceutical composition and method for preparing a pharmaceutical composition | |
| DE60327843D1 (en) | MEDICAMENT FORMULATIONS WITH DELAYED RELEASE WITH A CARRIER PEPTIDE | |
| AR036312A1 (en) | PHARMACEUTICAL COMPOSITION | |
| BR0013719A (en) | Controlled-release oral dosage, suitable for oral administration | |
| CR7938A (en) | PARENTERAL FORMULATIONS OF PEPTIDES FOR THE TREATMENT OF SYSTEMIC ERYTHEMATE LUPUS | |
| ES2194832T3 (en) | FORMULATIONS OF DITIAZEM WITH CONTROLLED ABSORPTION. | |
| SE9603480L (en) | Dosage form for hard soluble drugs | |
| CR7936A (en) | PARENTERAL FORMULATIONS OF A PEPTIDE FOR THE TREATMENT OF SITEMIC ERITEMATOSUS LUPUS | |
| WO2005010022A3 (en) | Agonist polypeptide of receptor for zot and zonulin | |
| CO4970695A1 (en) | PHARMACEUTICAL FORMULATIONS FOR CAPTOTECINE ANALOGS IN GELATIN CAPSULE | |
| AR006216A1 (en) | PHARMACEUTICAL COMPOSITIONS INCLUDING PEPTIDES FOR SUSTAINED RELEASE, METHOD FOR THE PREPARATION, USE OF A GELABLE PEPTIDE SALT TO PREPARE MEDICINES AND CONTAINING MEDICINES | |
| AR014884A1 (en) | USE OF AN IMMUNOGENIC ANGIOTENSIN CONJUGATE AND PHARMACEUTICAL COMPOSITION | |
| ES2188513T3 (en) | USE OF DEOXIPEGANINE FOR THE TREATMENT OF DRUG EPENDANCE. | |
| KR900011461A (en) | Therapeutics using trypstatin as an active ingredient | |
| CA2356306A1 (en) | Sulfated phosphatidylinositols, their preparation and use | |
| AR012638A1 (en) | USE OF PREGNAN-3-OL-20-ONAS FOR THE MANUFACTURE OF A USEFUL MEDICINAL PRODUCT TO PROVIDE PROGESTATIONAL THERAPY | |
| IT1291895B1 (en) | FLUID PHARMACEUTICAL PREPARATION BASED ON NIMESULIDE FOR ORAL AND RHINOPHARYNGAL USE |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |